From the Journals

Plant-based or keto diet? Novel study yields surprising results


 

Diet ‘tribes’

In a comment, Taylor Wallace, PhD, adjunct professor, department of nutrition and food studies, George Mason University, Fairfax, Va., said it’s important to note that “a ‘low-carb diet’ has yet to be defined, and many definitions exist.

“We really need a standard definition of what constitutes ‘low-carb’ so that studies can be designed and evaluated in a consistent manner. It’s problematic because, without a standard definition, the ‘diet tribe’ researchers (keto versus plant-based) always seem to find the answer that is in their own favor,” Dr. Wallace said. “This study does seem to use less than 20 grams of carbs per day, which in my mind is pretty low carb.”

Perhaps the most important caveat, he added, is that, in the real world, “most people don’t adhere to these very strict diets – not even for 2 weeks.”

The study was supported by the NIDDK Intramural Research Program, with additional NIH support from a National Institute of Nursing Research grant. One author has received reimbursement for speaking at conferences sponsored by companies selling nutritional products, serves on the scientific advisory council for Kerry Taste and Nutrition, and is part of an academic consortium that has received research funding from Abbott Nutrition, Nestec, and Danone. Dr. Hall and the other authors disclosed no relevant financial relationships. Dr. Wallace is principal and CEO of the Think Healthy Group, editor of the Journal of Dietary Supplements, and deputy editor of the Journal of the American College of Nutrition.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

To fast or not? The new dieting dilemma
Journal of Clinical Outcomes Management
Sotagliflozin’s trial data receives FDA welcome for NDA filing
Journal of Clinical Outcomes Management
Pressure builds on CDC to prioritize both diabetes types for vaccine
Journal of Clinical Outcomes Management
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Journal of Clinical Outcomes Management
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Journal of Clinical Outcomes Management
Low-carb diets boost diabetes remission rates, at least short term
Journal of Clinical Outcomes Management
Widespread liver disease missed in patients with T2D
Journal of Clinical Outcomes Management
Theory of Planned Behavior Provides A Theoretical Explanation For Enhanced Behavior Change With Genetic-Based Lifestyle Interventions
Journal of Clinical Outcomes Management
Protecting patients with diabetes from impact of COVID-19
Journal of Clinical Outcomes Management
Gestational diabetes carries CVD risk years later
Journal of Clinical Outcomes Management